We previously reported studies (2, 3) in which Salmonella typhimurium hybrids expressing S. typhosa antigens as the result of genetic exchange were employed in mouse protection and pathogenicity experiments. At an intraperitoneal dose level of 50 organisms, the degree of virulence exhibited by S. typhimurium hybrids expressing various combinations of S. typhosa Vi, flagella d, and somatic 9 antigens was not observed to differ from that of their virulent S. typhimurium parent. This indication that the virulence of these S. typhimurium hybrids was not affected by their expression of S. typhosa antigens did not seem to us at all remarkable; it was the result we had expected. We were concerned, however, by studies elsewhere (7, 9) in which other S. typhimurium hybrids, expressing the somatic 9 antigen as the result of inheritance of S. enteritidis genetic determinants, showed a 10-fold decrease in their virulence for mice upon intraperitoneal injection. This decrease in virulence was considered to have resulted from the qualitative change in the lipopolysaccharide antigenic side chain, i.e., the substitution of tyvelose (conferring 9 antigen specificity) for abequose (conferring the native, S. typhimurium 4 antigen specificity) in the repeating oligosaccharide units.
The notion of a qualitative change from the 4 antigen to the 9 antigen configuration affecting intraperitoneal mouse virulence seemed unacceptable to us, both from a priori considerations and from our previous experimental results with S. typhosa x S. typhimurium hybrids. And although we could see no reason why the genetic source of the 9 antigen, whether S. typhosa or S. enteritidis, should have a bearing on the outcome (so long as only a qualitative, as opposed to quantitative, change in the lipopolysaccharide was involved), we thought it worth comparing, within the same maternal S. typhimurium strain, 9-antigen-expressing hybrids of each paternal (with respect to the antigen determinants) genotype. In the present communication, we report the construction of such hybrids and the results of their employment in intraperitoneal mouse inoculation studies.
The derivation of the S. typhosa Hfr strain employed, WR4000, has been described previously (4). The S. enteritidis Hfr, WR4050, was derived in a similar manner by mating S. typhimurium Hfr SC-19 with an S. enteritidis strain obtained from Philip B. Carter, SE795 (1), and selecting an S. enteritidis hybrid inheriting the terminally transferred lactose utilization marker (lac) to which the sex factor, F, is linked. S. typhimurium Hfr SC-19 was originally derived in this manner from an Escherichia coli Hfr (8) . S. typhosa Hfr WR4000 and S. enteritidis Hfr WR4050 have the same transfer orientation; proB is the marker transferred earliest and lac is the last marker transferred before F. The strain used as the recipient for transfer of the antigen determining genes from Hfr strains WR4000 and WR4050 was S. typhimurium WR5005, a streptomycin-resistant mutant of the histidine-requiring, mousevirulent S. typhimurium strain used in our previous studies (2, 3), WR5004.
The selective media and mating procedures have been described previously (2, 5) . Streptomycin served as a counter selective agent against the Hfr strains. In the matings with S. enteritidis Hfr WR4050, and also with S. typhosa Hfr WR4000, S. typhimurium WR5005 hybrids were selected for receipt of the histidine synthesis (his) genetic determinant of the donor to which the genes determining the somatic 9 antigen are closely linked in S. typhosa (5) as well as in S. enteritidis (6) . As the genetic locus occupied by the determinants of the 4 antigen of S. typhimurium is allelic with the locus of the 9 antigens of S. typhosa and S. enteritidis (5, 6), S. typhimurium hybrids expressing the 9 anti- gen derived from either of these donors have lost their native 4 antigen. The somatic 5 antigen, which can not be expressed in the absence of the 4 antigen (5), also disappears from these 9-antigen-expressing hybrids. Three S. typhimurium WR5005 hybrids expressing somatic antigen 9 after mating with the S. enteritidis Hfr, two hybrids expressing somatic antigen 9 as the result of hybridization with the S. typhosa Hfr, and the parent S. typhimurium WR5005 were examined for mouse virulence by intraperitoneal inoculation. Groups of 10 mice (BALB/c females weighing 14 to 18 g) were inoculated with 0.5-ml saline suspensions of various dose levels of each organism. These doses ranged from a high of 50,000 organisms to a low of 10 organisms. At the lowest dose level, plating of 0.5-ml samples of the bacterial suspensions on meat extract agar indicated that between 5 to 14 viable organisms were being injected.
In three or more virulence titration experiments conducted with each of these hybrids and with their S. typhimurium WR5005 parent, no differences were observed among them with respect to the number of organisms capable of causing death of at least half of the animals tested, within a period of 15 days. At the 30-organism dose level, 50% end points were achieved, in all instances, within 13 days. A representative virulence titration of S. typhimurium WR5005, an S. enteritidis-fathered, 9-antigen-expressing S. typhimurium WR5005 hybrid, and an S. typhosa-fathered, 9-antigen-expressing S. typhimurium WR5005 hybrid is shown in Table 1 .
In terms of the time required to attain their 50% end points, the three S. enteritidis-derived S. typhimurium hybrids appeared fairly similar to their WR5005 parent. Thus, at a dose level of 50 organisms, these hybrids achieved their end points in 7 to 10 days, the S. typhimurium WR5005 parent in 8 to 11 days. The two S. typhosa derived hybrids generally took longer, reaching their end points at the 50-organism dose level in 10 to 13 days. We would be hesitant about assigning any particular significance to these differences. We would not hesitate, however, to conclude that the qualitative change from 4 antigen to 9 antigen specificity is not, per se, responsible for any alteration of mouse virulence in hybrids of S. typhimurium WR5005 that can be measured by intraperitoneal inoculation.
